Longitudinally Extensive Transverse Myelitis: One Disease, Variable Outcomes-A Case Series
Shyam Chandrasekar1, Joseph John1, Amit Kumar Satapathy1
1Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Abstract:
Longitudinal extensive transverse myelitis (LETM) is a rare form of widespread inflammation of the spinal cord causing T2 hyperintensity in spinal magnetic resonance imaging (MRI) extending across three or more vertebral segments. It is an acute onset of sensory, motor, and autonomic dysfunction of variable etiology with a likely poor outcome. We present a case series of three cases wherein children between the ages of 4 and 13 years had diverse symptoms from gradual painless loss of vision in both eyes with headache, vomiting and seizure, and a normal central nervous system examination except involvement of the optic nerve to another child with abdominal pain, urinary retention and constipation for 3 days with exaggerated DTR, and patchy sensory loss without any definite sensory level, and to the third child with fever and weakness of lower limbs, hypotonia and grade 1-2/5 power in lower limbs and normal upper limb power. Contrast-enhanced MRI spine of all children showed long segment T2 hyperintensity with variable involvement of the brain. The first two children were treated with pulsed dose methylprednisolone, and the last child received intravenous immunoglobulin followed by methylprednisolone. All were followed with oral prednisolone. LETM has a varied presentation with different etiologies. Antineuromyelitis optica immunoglobulin G (IgG) antibody (Aquaporin-4 IgG) and antimyelin oligodendrocyte glycoprotein antibody are strongly recommended though they may not be locally available or not affordable. Early and aggressive immunomodulatory therapy may help faster recovery, as did with two of our three children.
Insights
Longitudinal extensive transverse myelitis (LETM) is a rare spinal cord inflammation with varied symptoms and causes. Early immunomodulatory therapy may improve outcomes in children with LETM.
Area of Science:
- Neurology
- Pediatrics
- Immunology
Background:
- Longitudinal extensive transverse myelitis (LETM) is a rare, severe spinal cord inflammation.
- LETM presents acutely with sensory, motor, and autonomic dysfunction, often with poor prognosis.
- Pediatric LETM cases exhibit diverse clinical presentations and etiologies.
Purpose of the Study:
- To present a case series of three children diagnosed with LETM.
- To highlight the varied clinical manifestations and diagnostic challenges of pediatric LETM.
- To discuss the role of immunomodulatory therapies in managing LETM.
Main Methods:
- Case series analysis of three pediatric patients (ages 4-13) with LETM.
- Clinical assessment, neurological examination, and contrast-enhanced MRI spine were performed.
- Treatment involved pulsed dose methylprednisolone, intravenous immunoglobulin, and oral prednisolone.
Main Results:
- Patients presented with diverse symptoms including vision loss, seizures, abdominal pain, urinary retention, constipation, and limb weakness.
- Spinal MRI revealed long segment T2 hyperintensity in all cases, with some brain involvement.
- Two of three children showed faster recovery with early immunomodulatory treatment.
Conclusions:
- LETM in children has varied presentations and etiologies.
- Testing for Aquaporin-4 IgG and anti-myelin oligodendrocyte glycoprotein antibodies is recommended.
- Prompt and aggressive immunomodulatory therapy can facilitate recovery in pediatric LETM.


